Abstract

The biomaterial bacterial cellulose (BC) represents an innovative approach for overcoming reconstructive problems associated with extended vascular diseases by providing small caliber vascular grafts (diameter 1.0-3.7, length 5.0-10.0, and wall-thickness 0.7 mm). In a first microsurgical study, the BC implants were attached in an artificial defect of the carotid artery of rats for 1 year. These long term results show the incorporation of the BC under formation of neointima and ingrowth of active fibroblasts. In a second study, the grafts were used to replace the carotid arteries of pigs. After 3 months, these grafts were removed and analyzed both macro- and microscopically. Seven grafts (87.5%) were patent whereas one graft was found occluded. These data indicate that the innovative BC engineering technique results in the production of stable vascular conduits and confirm a highly attractive approach to in vivo tissue engineered blood vessels as part of programs in cardiovascular surgery.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.